Pieris Pharmaceuticals, Inc.

  • Home
  • About
  • Platform
  • Pipeline
  • Patients
  • Investors
    • Overview
    • News & Events
    • Publications
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
    • Job Openings
  • Contact
  • News & Events

  • Overview
  • Press Releases
  • Media
  • IR Calendar
  • Email Alerts
Sep 14, 2018 8:00am EDT

Pieris Pharmaceuticals to Present Preclinical Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at the ERS International Congress 2018

Sep 10, 2018 8:00am EDT

Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of Directors

Sep 04, 2018 8:00am EDT

Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy

Aug 30, 2018 8:00am EDT

Pieris Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

Aug 09, 2018 7:00am EDT

Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Aug 08, 2018 8:00am EDT

Pieris Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference

Aug 01, 2018 8:00am EDT

Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018

May 31, 2018 8:00am EDT

Pieris Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference

May 10, 2018 7:00am EDT

Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update

May 03, 2018 8:00am EDT

Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference

  • Previous
  • 1…
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • …25
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2023 Pieris Pharmaceuticals, Inc. All Rights Reserved.
Imprint Privacy Policy Disclaimer Sitemap Contact Us Manage Cookie Preferences